Taken together, our work presents a model in which risk factors with population-level associations with AD activate TRPA1, alter endogenous steroid precursors in Gram-positive commensals, and/or suppress ceramide-sphingolipid metabolism in Gram-negative commensals. Here, TRPA1 is linked to Alzheimer disease.